We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
Cap. Flow
-$890M
Cap. Flow %
-2.03%
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$111M
2
VZ icon
Verizon
VZ
+$103M
3
T icon
AT&T
T
+$103M
4
KR icon
Kroger
KR
+$97.1M
5
MMM icon
3M
MMM
+$92.9M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$138M
2
TSLA icon
Tesla
TSLA
+$110M
3
JPM icon
JPMorgan Chase
JPM
+$103M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$89.4M
5
AAPL icon
Apple
AAPL
+$85.9M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Healthcare 16.25%
3 Financials 11.85%
4 Industrials 11.44%
5 Consumer Discretionary 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
1901
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$385K ﹤0.01%
17,968
-806
-4% -$17.2K
TVTX icon
1902
Travere Therapeutics
TVTX
$5.82B
$385K ﹤0.01%
18,286
-12,691
-41% -$269K
NGM
1903
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$384K ﹤0.01%
+76,477
New +$479K
TGI
1904
DELISTED
Triumph Group
TGI
$383K ﹤0.01%
36,441
-20,723
-36% -$214K
DFH icon
1905
Dream Finders Homes
DFH
$1.3B
$383K ﹤0.01%
+44,267
New +$444K
CCO icon
1906
Clear Channel Outdoor Holdings
CCO
$1.23B
$383K ﹤0.01%
+364,739
New +$459K
PRAX icon
1907
Praxis Precision Medicines
PRAX
$10.2B
$382K ﹤0.01%
10,702
-6,081
-36% -$190K
CLDX icon
1908
Celldex Therapeutics
CLDX
$3.47B
$382K ﹤0.01%
8,568
-660
-7% -$23.6K
TS icon
1909
Tenaris
TS
$26.9B
$381K ﹤0.01%
10,849
-960
-8% -$30.7K
THS
1910
DELISTED
Treehouse Foods
THS
$381K ﹤0.01%
7,811
-20,696
-73% -$985K
SPT icon
1911
Sprout Social
SPT
$611M
$379K ﹤0.01%
6,708
-2,439
-27% -$143K
HLIO icon
1912
Helios Technologies
HLIO
$2.71B
$376K ﹤0.01%
6,906
-976
-12% -$52.6K
BEAM icon
1913
Beam Therapeutics
BEAM
$2.79B
$375K ﹤0.01%
9,599
-42
-0.4% -$1.88K
FLWS icon
1914
1-800-Flowers.com
FLWS
$258M
$374K ﹤0.01%
39,125
-118,082
-75% -$938K
TTGT icon
1915
TechTarget
TTGT
$273M
$370K ﹤0.01%
8,400
-1,366
-14% -$71.6K
NWSA icon
1916
News Corp Class A
NWSA
$15.4B
$367K ﹤0.01%
20,281
-131,866
-87% -$2.29M
GDOT icon
1917
Green Dot
GDOT
$762M
$367K ﹤0.01%
23,184
+10,501
+83% +$194K
SRPT icon
1918
Sarepta Therapeutics
SRPT
$1.88B
$366K ﹤0.01%
2,826
+95
+3% +$11K
VECO icon
1919
Veeco
VECO
$3.03B
$365K ﹤0.01%
19,658
+3,683
+23% +$69.2K
SMR icon
1920
NuScale Power
SMR
$3.95B
$365K ﹤0.01%
35,561
+3,300
+10% +$36.5K
AXGN icon
1921
Axogen
AXGN
$2.6B
$361K ﹤0.01%
36,129
-25,305
-41% -$281K
ITOT icon
1922
iShares Core S&P Total US Stock Market ETF
ITOT
$97.7B
$360K ﹤0.01%
+4,249
New +$363K
FG icon
1923
F&G Annuities & Life
FG
$3.57B
$359K ﹤0.01%
+17,998
New +$367K
BECN
1924
DELISTED
Beacon Roofing Supply, Inc.
BECN
$359K ﹤0.01%
6,800
+2,946
+76% +$166K
GH icon
1925
Guardant Health
GH
$22.4B
$351K ﹤0.01%
+13,418
New +$614K
75 76
77
78 79

Similar funds

CTC (Chicago Trading Company)
CTC (Chicago Trading Company) Chicago, Illinois $217B AUM 46.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

AQR Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
  • AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
  • AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
  • AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
  • AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
  • AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
  • AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.

Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.